Position in BMY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,291,254
+$120,715 QoQ
Shares Held
57,120
+9.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#187
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $69,954,680 across 17 Drug Manufacturers - General names. BMY ranks #6 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,352 | $24,410,801 | |
| 2 | ABBV |
AbbVie Inc.
|
52,930 | $13,319,305 | |
| 3 | JNJ |
Johnson & Johnson
|
38,760 | $9,843,877 | |
| 4 | PFE |
Pfizer Inc
|
228,411 | $5,500,136 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,895 | $3,970,007 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
57,120 | $3,291,254 | |
| 7 | AMGN |
Amgen Inc
|
8,216 | $2,975,177 | |
| 8 | NVO |
Novo Nordisk A S
|
30,253 | $1,450,328 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,291,254 | 57,120 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $3,170,539 | 52,276 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $2,668,735 | 49,476 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,416,861 | 31,416 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $1,453,228 | 31,394 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $1,616,235 | 26,500 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,560,660 | 27,593 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,632,707 | 31,556 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $1,327,464 | 31,964 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,541,108 | 28,418 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $1,567,417 | 30,548 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $1,843,698 | 31,766 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,678,879 | 26,253 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,809,753 | 26,111 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $4,002,506 | 55,629 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $3,886,703 | 54,673 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $4,000,535 | 51,955 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $3,794,273 | 51,955 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $2,159,367 | 34,633 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $5,034,775 | 85,090 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $5,722,665 | 85,643 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $5,341,303 | 84,608 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $5,254,251 | 84,705 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $4,334,248 | 71,890 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $4,111,590 | 69,925 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $3,623,322 | 65,004 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||